Eam Global Investors LLC Invitae Corp Transaction History

Eam Global Investors LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$17.37 - $26.27 $1.87 Million - $2.82 Million	-107,418 Closed	0 $0
Q1 2019 May 10, 2019	SELL	$10.65 - $25.75 $333,376 - $806,052	-31,303 Reduced 22.57%	107,418 $2.52 Million
Q3 2018 Nov 08, 2018	BUY	$7.54 - $18.31 $1.05 Million - $2.54 Million	138,721 New	138,721 $2.32 Million

7.66M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Eam Global Investors LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Global Investors LLC with notifications on news.